{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:05:00Z","timestamp":1780607100486,"version":"3.54.1"},"reference-count":130,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"India Ministry of Science & Technology Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbcan.2026.189582","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:48:52Z","timestamp":1774928932000},"page":"189582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cysteine proteases in oral potentially malignant disorders: Molecular drivers, diagnostic signatures, and therapeutic opportunities"],"prefix":"10.1016","volume":"1881","author":[{"given":"Soumyajit","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha Rani","family":"Kokkanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandita","family":"Parida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul Anand","family":"Bajoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189582_bb0005","article-title":"Oral potentially malignant disorders: etiology, pathogenesis, and transformation into oral cancer","volume":"13","author":"Kumari","year":"2022","journal-title":"Front. Pharmacol. Front. Media S.A."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189582_bb0010","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1600-0714.2007.00582.x","article-title":"Nomenclature and classification of potentially malignant disorders of the oral mucosa","volume":"36","author":"Warnakulasuriya","year":"2007","journal-title":"J. Oral Pathol. Med."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189582_bb0015","doi-asserted-by":"crossref","first-page":"9160","DOI":"10.3390\/ijerph17249160","article-title":"Oral cancer and precancer: a narrative review on the relevance of early diagnosis","volume":"17","author":"Abati","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"15","key":"10.1016\/j.bbcan.2026.189582_bb0020","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.3390\/cancers13153696","article-title":"Overview of oral potentially malignant disorders: from risk factors to specific therapies","volume":"13","author":"Lorini","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189582_bb0025","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/prca.200800242","article-title":"Activity-based mass spectrometric characterization of proteases and inhibitors in human saliva","volume":"3","author":"Sun","year":"2009","journal-title":"Proteomics Clin. Appl."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189582_bb0030","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/bjc.2017.409","article-title":"Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation","volume":"118","author":"Nieminen","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189582_bb0035","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/odi.12069","article-title":"The diagnostic potential of salivary protease activities in periodontal health and disease","volume":"19","author":"Thomadaki","year":"2013","journal-title":"Oral Dis."},{"key":"10.1016\/j.bbcan.2026.189582_bb0040","series-title":"Encyclopedia of Biological Chemistry","first-page":"589","article-title":"Cysteine proteases","author":"Buttle","year":"2013"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189582_bb0045","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3390\/microorganisms11061397","article-title":"Roles of cysteine proteases in biology and pathogenesis of parasites","volume":"11","author":"Yang","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.bbcan.2026.189582_bb0050","first-page":"7","article-title":"Cysteine proteases: modes of activation and future prospects as pharmacological targets","author":"Verma","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189582_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00430-016-0454-1","article-title":"Microbial inhibitors of cysteine proteases","volume":"205","author":"K\u0119dzior","year":"2016","journal-title":"Med. Microbiol. Immunol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189582_bb0060","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s11912-024-01562-1","article-title":"Oral pre-malignancy: An update on novel therapeutic approaches","volume":"26","author":"Naara","year":"2024","journal-title":"Curr. Oncol. Rep."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189582_bb0065","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5301\/JBM.2011.8833","article-title":"Proteolytic profile of cysteine proteases and inhibitors determines tumor cell phenotype in squamous cell carcinoma of the head and neck","volume":"26","author":"Strojan","year":"2011","journal-title":"Int. J. Biol. Markers"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189582_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005850","article-title":"Update on drug development targeting parasite cysteine proteases. Mitreva M, editor","volume":"12","author":"McKerrow","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbcan.2026.189582_bb0075","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2017\/30740.10274","article-title":"Role of cathepsin b as a marker of malignant transformation in oral lichen planus: An immunohistochemical study","author":"Satelur","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12903-022-02052-1","article-title":"Association of salivary cathepsin b in different histological grades among patients presenting with oral squamous cell carcinoma","volume":"22","author":"Shabbir","year":"2022","journal-title":"BMC Oral Health"},{"issue":"22","key":"10.1016\/j.bbcan.2026.189582_bb0085","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jpcb.2c01484","article-title":"Serine and cysteine peptidases: so similar, yet different. How the active-site electrostatics facilitates different reaction mechanisms","volume":"126","author":"Gisdon","year":"2022","journal-title":"J. Phys. Chem. B"},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2026.189582_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cccn.2003.12.016","article-title":"Cysteine proteases as disease markers","volume":"342","author":"Berdowska","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbcan.2026.189582_bb0095","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2019.4722","article-title":"Cathepsin b defines leader cells during the collective invasion of salivary adenoid cystic carcinoma","author":"Wu","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1523\/JNEUROSCI.1211-20.2020","article-title":"Legumain induces oral cancer pain by biased agonism of protease-activated receptor-2","volume":"41","author":"Tu","year":"2021","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189582_bb0105","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s13577-020-00385-z","article-title":"Matriptase and prostasin proteolytic activities are differentially regulated in normal and wounded skin","volume":"33","author":"Chang","year":"2020","journal-title":"Hum. Cell"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189582_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110935","article-title":"Efficacy of a cysteine protease inhibitor compared with enalapril in murine heart failure models","volume":"27","author":"Aluja","year":"2024","journal-title":"iScience"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189582_bb0115","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4155\/fmc.14.73","article-title":"The current stage of cathepsin b inhibitors as potential anticancer agents","volume":"6","author":"Kos","year":"2014","journal-title":"Future Med. Chem."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189582_bb0120","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/cells13110917","article-title":"Unveiling the roles of cysteine proteinases f and w: from structure to pathological implications and therapeutic targets","volume":"13","author":"Zdravkova","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189582_bb0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.biochi.2019.05.002","article-title":"Cystatins in cancer progression: more than just cathepsin inhibitors","volume":"166","author":"Breznik","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.bbcan.2026.189582_bb0130","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2020\/44276.13856","article-title":"Molecular mechanism of oral submucous fibrosis induced by arecoline: a literature review","author":"Cui","year":"2020","journal-title":"J. Clin. Diagn. Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189582_bb0135","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF00123393","article-title":"Expression of cysteine protease inhibitors in human gliomas and meningiomas","volume":"14","author":"Sivaparvathi","year":"1996","journal-title":"Clin. Exp. Metastasis"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189582_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107347","article-title":"Extracellular proteolysis in cancer: proteases, substrates, and mechanisms in tumor progression and metastasis","volume":"300","author":"Radisky","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189582_bb0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.7150\/thno.4068","article-title":"Protease-activated drug development","volume":"2","author":"Choi","year":"2012","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189582_bb0150","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/cells8030264","article-title":"Cysteine cathepsins and their extracellular roles: shaping the microenvironment","volume":"8","author":"Vidak","year":"2019","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189582_bb0155","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ncb3388","article-title":"Cathepsin-B-mediated cleavage of disabled-2 regulates TGF-\u03b2-induced autophagy","volume":"18","author":"Jiang","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189582_bb0160","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/aps.2016.93","article-title":"Cathepsin l upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in a549 cells","volume":"37","author":"Han","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbcan.2026.189582_bb0165","first-page":"13","article-title":"Oral submucosal fibrosis: a comprehensive review on pathogenesis, diagnosis, therapeutics and computational advances","author":"Nitin","year":"2026","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189582_bb0170","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.tripleo.2010.05.070","article-title":"Caspase cascade pathways in apoptosis of oral lichen planus","volume":"110","author":"Mattila","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41368-024-00344-6","article-title":"Oral submucous fibrosis: pathogenesis and therapeutic approaches","volume":"17","author":"Tang","year":"2025","journal-title":"Int. J. Oral Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189582_bb0180","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF-\u03b2 signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189582_bb0185","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00852-24","article-title":"Exploring oral microbiome in oral squamous cell carcinoma across environment-associated sample types. Xu ZZ, editor","volume":"13","author":"Wang","year":"2025","journal-title":"Microbiol. Spectrum"},{"key":"10.1016\/j.bbcan.2026.189582_bb0190","first-page":"11","article-title":"Cystatin-B negatively regulates the malignant characteristics of oral squamous cell carcinoma possibly via the epithelium proliferation\/differentiation program","author":"Xu","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189582_bb0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41416-021-01411-z","article-title":"Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology","volume":"125","author":"Sathasivam","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189582_bb0200","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.7150\/jca.86531","article-title":"The role of cathepsin b in pathophysiologies of non-tumor and tumor tissues: a systematic review","volume":"14","author":"Wang","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189582_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2021.105116","article-title":"Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma","volume":"126","author":"Wang","year":"2021","journal-title":"Arch. Oral Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189582_bb0210","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.oraloncology.2006.08.009","article-title":"The upregulation of cystatin c in oral submucous fibrosis","volume":"43","author":"Chung-Hung","year":"2007","journal-title":"Oral Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189582_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152165","article-title":"Cathepsin B expression and the correlation with clinical aspects of oral squamous cell carcinoma. Suzuki H, editor","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2026.189582_bb0220","first-page":"4","article-title":"A meta-analysis reveals the protein profile associated with malignant transformation of oral leukoplakia. Frontiers","author":"Normando","year":"2023","journal-title":"Oral Health"},{"key":"10.1016\/j.bbcan.2026.189582_bb0225","first-page":"14","article-title":"Cathepsins in oral diseases: mechanisms and therapeutic implications","author":"Jiang","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189582_bb0230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/odi.12378","article-title":"The role of cathepsin k in oral and maxillofacial disorders","volume":"22","author":"Wen","year":"2016","journal-title":"Oral Dis."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189582_bb0235","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1601-0825.2003.00998.x","article-title":"Expression of caspase-3 and structural changes associated with apoptotic cell death of keratinocytes in oral lichen planus","volume":"10","author":"Tob\u00f3n-Arroyave","year":"2004","journal-title":"Oral Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0240","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189582_bb0245","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.bbagen.2014.03.017","article-title":"Cysteine cathepsins and extracellular matrix degradation","volume":"1840","author":"Fonovi\u0107","year":"2014","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189582_bb0250","first-page":"1","article-title":"The intersection of genetic and molecular biology in oral potentially malignant disorders: identifying key biomarkers and pathways for clinical intervention","volume":"13","author":"K HS","year":"2024","journal-title":"Int. J. Histopathol. Interpret."},{"key":"10.1016\/j.bbcan.2026.189582_bb0255","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-0043-1772214","article-title":"Cystatin a down-regulation in head and neck squamous cell carcinoma cell lines decreases cancer hallmark signatures","volume":"59","author":"Boora","year":"2023","journal-title":"Ann. Natl. Acad. Med. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0260","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12105-025-01787-x","article-title":"Loss of heterozygosity in oral potentially malignant disorders and oral squamous cell carcinoma \u2013 a scoping review","volume":"19","author":"Kavitha","year":"2025","journal-title":"Head Neck Pathol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189582_bb0265","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3390\/genes14081578","article-title":"Review of disease-specific microRNAs by strategically bridging genetics and epigenetics in oral squamous cell carcinoma","volume":"14","author":"Gintoni","year":"2023","journal-title":"Genes (Basel)"},{"issue":"40","key":"10.1016\/j.bbcan.2026.189582_bb0270","doi-asserted-by":"crossref","first-page":"68641","DOI":"10.18632\/oncotarget.19817","article-title":"Targeting the PI3K\/AKT\/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma in vitro and in vivo","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189582_bb0275","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/mc.23511","article-title":"Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K\/AKT\/mTOR signaling pathway","volume":"62","author":"Hu","year":"2023","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"13","key":"10.1016\/j.bbcan.2026.189582_bb0285","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.3390\/ijms21134682","article-title":"Wnt\/\u03b2-catenin signaling in oral carcinogenesis","volume":"21","author":"Reyes","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2021.5056","article-title":"Therapeutic strategies targeting Wnt\/\u03b2-catenin signaling for colorectal cancer (review)","volume":"49","author":"Ji","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189582_bb0295","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3892\/ol.2016.5500","article-title":"Regulation of cell migration via the EGFR signaling pathway in oral squamous cell carcinoma cells","volume":"13","author":"Ohnishi","year":"2017","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189582_bb0300","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/cam4.2772","article-title":"EGFR enhances the stemness and progression of oral cancer through inhibiting autophagic degradation of SOX2","volume":"9","author":"Lv","year":"2020","journal-title":"Cancer Med."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189582_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/ph16111558","article-title":"Repurposing EGFR inhibitors for oral cancer pain and opioid tolerance","volume":"16","author":"Santi","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2012","key":"10.1016\/j.bbcan.2026.189582_bb0310","first-page":"1","article-title":"Epithelial-mesenchymal transition in oral squamous cell carcinoma","author":"Krisanaprakornkit","year":"2012","journal-title":"ISRN Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0315","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41598-025-87790-2","article-title":"Novel transcripts of EMT driving the malignant transformation of oral submucous fibrosis","volume":"15","author":"Shetty","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189582_bb0320","first-page":"111","article-title":"Biomarkers of epithelial-mesenchymal transition: E-cadherin and beta-catenin in malignant transformation of oral lesions","volume":"58","author":"Yim","year":"2024","journal-title":"Can. J. Dent. Hyg."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189582_bb0325","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/jomfp.JOMFP_151_18","article-title":"Loss of heterozygosity as a marker to predict progression of oral epithelial dysplasia to oral squamous cell carcinoma","volume":"22","author":"Rao","year":"2018","journal-title":"J. Oral Maxillofacial Pathol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189582_bb0330","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s100380170069","article-title":"Frequent loss of heterozygosity at 3p25-p26 is associated with invasive oral squamous cell carcinoma","volume":"46","author":"Kayahara","year":"2001","journal-title":"J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189582_bb0335","article-title":"Microsatellite instability and loss of heterozygosity as prognostic markers in oral squamous cell carcinoma: molecular mechanisms, detection techniques, and therapeutic strategies","volume":"63","author":"Arslan Bozdag","year":"2024","journal-title":"Genes Chromosom. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0340","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s12672-025-03508-w","article-title":"From gum inflammation to oral cancers: pyroptosis as the molecular torchbearer in periodontitis-driven carcinogenesis","volume":"16","author":"Ghasemzadeh","year":"2025","journal-title":"Discov. Oncol."},{"issue":"49","key":"10.1016\/j.bbcan.2026.189582_bb0345","doi-asserted-by":"crossref","first-page":"29047","DOI":"10.18632\/oncotarget.25540","article-title":"Oral inflammation promotes oral squamous cell carcinoma invasion","volume":"9","author":"Goertzen","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0350","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12672-025-02073-6","article-title":"Inflammatory cytokines and oral cancer risk: an integrated study combining two-sample mendelian randomization with experimental validation","volume":"16","author":"Xia","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbcan.2026.189582_bb0355","first-page":"9","article-title":"Insights into the role of matrix metalloproteinases in cancer and its various therapeutic aspects: a review","author":"Mustafa","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbcan.2026.189582_bb0360","doi-asserted-by":"crossref","DOI":"10.4317\/medoral.23305","article-title":"Prognostic value of the immunohistochemical detection of epithelial-mesenchymal transition biomarkers in oral epithelial dysplasia: a systematic review","author":"Morais","year":"2020","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189582_bb0365","doi-asserted-by":"crossref","first-page":"338","DOI":"10.32074\/1591-951X-N867","article-title":"The oral microbiome and its role in oral squamous cell carcinoma: a systematic review of microbial alterations and potential biomarkers","volume":"116","author":"Crispino","year":"2024","journal-title":"Pathologica"},{"key":"10.1016\/j.bbcan.2026.189582_bb0370","first-page":"2","article-title":"Inflammatory mediators in oral cancer: pathogenic mechanisms and diagnostic potential","author":"Niklander","year":"2021","journal-title":"Front. Oral Health."},{"key":"10.1016\/j.bbcan.2026.189582_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjoms.2024.03.001","article-title":"Prognostic biomarkers for malignant progression of oral epithelial dysplasia: an updated systematic review and meta-analysis","author":"Turton","year":"2024","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189582_bb0380","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S1368-8375(03)00034-4","article-title":"Quantitative analysis of cathepsin l mRNA and protein expression during oral cancer progression","volume":"39","author":"Macabeo-Ong","year":"2003","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0385","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12903-018-0504-8","article-title":"Putative salivary protein biomarkers for the diagnosis of oral lichen planus: a case-control study","volume":"18","author":"Talungchit","year":"2018","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.bbcan.2026.189582_bb0390","series-title":"FGA139, a Novel Cysteine Protease Inhibitor, Exhibits Anti-Inflammatory and Neuroprotective Activity and Reveals Microglial Modulation Via Multi-Omics Profiling [Internet]","author":"Canseco-Rodr\u00edguez","year":"2025"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189582_bb0395","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/jpm15040126","article-title":"PD-L1\/PD-1 expression in the treatment of oral squamous cell carcinoma and oral potentially malignant disorders: an overview of reviews","volume":"15","author":"Al-Azzawi","year":"2025","journal-title":"J. Pers. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189582_bb0400","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/jpm13030565","article-title":"Targeted therapy for orofacial pain: a novel perspective for precision medicine","volume":"13","author":"Raman","year":"2023","journal-title":"J. Pers. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189582_bb0405","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/pharmaceutics17050606","article-title":"Enzyme-based anti-inflammatory therapeutics for inflammatory diseases","volume":"17","author":"Narayanan","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbcan.2026.189582_bb0410","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.biocel.2016.08.030","article-title":"Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin c elevate active cathepsin s and suppress active cathepsin l in breast cancer cells","volume":"79","author":"Wilder","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0415","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1097-0282(1999)51:1<99::AID-BIP11>3.0.CO;2-R","article-title":"Structural basis of inhibition of cysteine proteases by e-64 and its derivatives","volume":"51","author":"Matsumoto","year":"1999","journal-title":"Biopolymers"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189582_bb0420","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrd.2016.207","article-title":"Drops osteoporosis drug odanacatib","volume":"15","author":"Merck","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"19_Supplement","key":"10.1016\/j.bbcan.2026.189582_bb0425","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1158\/1538-7445.AM2014-1803","article-title":"Abstract 1803: a new spectrum-selective cathepsin inhibitor, VBY-825, inhibits bone destruction in a syngeneic 5TGM1 multiple myeloma mouse model","volume":"74","author":"Suominen","year":"2014","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189582_bb0430","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.biochi.2010.04.023","article-title":"Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model","volume":"92","author":"Elie","year":"2010","journal-title":"Biochimie"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189582_bb0435","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/medicina57060591","article-title":"Anti-inflammatory and mineralization effects of bromelain on lipopolysaccharide-induced inflammation of human dental pulp cells","volume":"57","author":"Hong","year":"2021","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.bbcan.2026.189582_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/976203","article-title":"Properties and therapeutic application of bromelain: a review","volume":"2012","author":"Pavan","year":"2012","journal-title":"Biotechnol. Res. Int."},{"key":"10.1016\/j.bbcan.2026.189582_bb0445","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1007\/s002800170003","article-title":"Oral therapy with proteolytic enzymes decreases excessive TGF-\u03b2 levels in human blood","volume":"47","author":"Desser","year":"2001","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189582_bb0450","article-title":"Innovative anti-fibrotic strategy using a bromelain containing mucoadhesive patch for effective collagen breakdown and cytotoxicity in oral submucous fibrosis","volume":"42","author":"Bajoria","year":"2025","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.bbcan.2026.189582_bb0455","series-title":"Potential Applications of Hydroxy Methyl Cellulose Mucoadhesive Buccal Patch Containing Zingibain for Management of Oral Potentially Malignant Disorders","first-page":"020002","author":"Das","year":"2023"},{"issue":"15","key":"10.1016\/j.bbcan.2026.189582_bb0460","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.3390\/molecules27155001","article-title":"Evaluating the properties of ginger protease-degraded collagen hydrolysate and identifying the cleavage site of ginger protease by using an integrated strategy and LC-MS technology","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189582_bb0465","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/antiox13080928","article-title":"Papain suppresses atopic skin inflammation through anti-inflammatory activities using in vitro and in vivo models","volume":"13","author":"Kim","year":"2024","journal-title":"Antioxidants"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189582_bb0470","first-page":"73","article-title":"No title","volume":"9","author":"Vivek","year":"2021","journal-title":"J. Res. Med. Dent. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0475","doi-asserted-by":"crossref","DOI":"10.2174\/0118742106301039240520093732","article-title":"A study on the correlation between the expression of a cysteine protease, cathepsin l, and its inhibitor, cystatin a, in oral lichen planus","volume":"18","author":"Talungchit","year":"2024","journal-title":"Open Dent. J."},{"key":"10.1016\/j.bbcan.2026.189582_bb0480","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/DDDT.S285852","article-title":"Current status and perspectives of protease inhibitors and their combination with nanosized drug delivery systems for targeted cancer therapy","volume":"15","author":"Rudzi\u0144ska","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189582_bb0485","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.3390\/ma3031928","article-title":"Targeted delivery of protein drugs by nanocarriers","volume":"3","author":"Solaro","year":"2010","journal-title":"Materials"},{"key":"10.1016\/j.bbcan.2026.189582_bb0490","first-page":"4","article-title":"Revolutionizing orofacial pain management: the promising potential of stem cell therapy","author":"Ren","year":"2023","journal-title":"Front. Pain Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0495","first-page":"193","article-title":"No title","volume":"41","author":"Nguyen Huu","year":"2021","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189582_bb0500","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3390\/biomedicines13071545","article-title":"Proteolytic activity inhibition in gingival fluid by cysteine protease inhibitors obtained from egg white and Fallopia japonica extract: an in vitro study","volume":"13","author":"Siewi\u0144ski","year":"2025","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189582_bb0505","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/jnc.13927","article-title":"The therapeutic potential of targeting chemokine signalling in the treatment of chronic pain","volume":"141","author":"Montague","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbcan.2026.189582_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177294","article-title":"Beyond chemotherapy: exploring 5-FU resistance and stemness in colorectal cancer","volume":"991","author":"Singh","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189582_bb0515","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7150\/ntno.84995","article-title":"Biogenic zinc oxide nanoparticles synthesized from Tinospora cordifolia induce oxidative stress, mitochondrial damage and apoptosis in colorectal cancer","volume":"8","author":"Berehu","year":"2024","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.bbcan.2026.189582_bb0520","first-page":"10","article-title":"2-dimensional in vitro culture assessment of ovarian cancer cell line using cost effective silver nanoparticles from Macrotyloma uniflorum seed extracts","author":"Lavudi","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0525","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1038\/s41598-022-11043-9","article-title":"Role of cathepsin k in the expression of mechanical hypersensitivity following intra-plantar inflammation","volume":"12","author":"Paracha","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189582_bb0530","article-title":"Mucoadhesive drug delivery system for oral submucous fibrosis in three-dimensional multicellular and in vivo models: novel approach towards translational therapeutics","volume":"42","author":"Viswanathan","year":"2025","journal-title":"Materialia (Oxf.)"},{"key":"10.1016\/j.bbcan.2026.189582_bb0535","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.sajb.2022.09.037","article-title":"Anti-tumour efficacy of Musa Paradisiaca flower extracts on DMBA induced mammary carcinogenesis in female Wistar rats","volume":"151","author":"Lavudi","year":"2022","journal-title":"S. Afr. J. Bot."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189582_bb0540","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.apsb.2015.08.001","article-title":"Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors","volume":"5","author":"Siklos","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189582_bb0545","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0968-0896(99)00008-5","article-title":"Cysteine protease inhibitors as chemotherapy for parasitic infections","volume":"7","author":"McKerrow","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbcan.2026.189582_bb0550","series-title":"Targeting SLC7A11-Mediated Cysteine Metabolism for the Treatment of Trastuzumab Resistant HER2 Positive Breast cancer [Internet]","author":"Hua","year":"2025"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189582_bb0555","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1021\/acs.jctc.2c00294","article-title":"Testing affordable strategies for the computational study of reactivity in cysteine proteases: the case of SARS-CoV-2 3CL protease inhibition","volume":"18","author":"Ramos-Guzm\u00e1n","year":"2022","journal-title":"J. Chem. Theory Comput."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0560","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/targets3010008","article-title":"From bench to bedside: transforming cancer therapy with protease inhibitors","volume":"3","author":"Shoari","year":"2025","journal-title":"Targets"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189582_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005639","article-title":"The diverse roles of cysteine proteases in parasites and their suitability as drug targets. Brindley PJ, editor","volume":"12","author":"McKerrow","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189582_bb0570","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.3390\/molecules27227728","article-title":"Covalent warheads targeting cysteine residue: the promising approach in drug development","volume":"27","author":"Huang","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0575","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nsmb.2203","article-title":"New approaches for dissecting protease functions to improve probe development and drug discovery","volume":"19","author":"Deu","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189582_bb0580","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1128\/AAC.00436-07","article-title":"A cysteine protease inhibitor cures chagas disease in an Immunodeficient-mouse model of infection","volume":"51","author":"Doyle","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"63","key":"10.1016\/j.bbcan.2026.189582_bb0585","doi-asserted-by":"crossref","first-page":"36699","DOI":"10.1039\/C9RA07161J","article-title":"Apoferritin encapsulation of cysteine protease inhibitors for cathepsin l inhibition in cancer cells","volume":"9","author":"Quilles Junior","year":"2019","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189582_bb0590","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1367-5931(02)00345-9","article-title":"Recent advances in the synthesis, design and selection of cysteine protease inhibitors","volume":"6","author":"Hernandez","year":"2002","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0595","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-024-02005-y","article-title":"Drug resistance mechanisms and treatment strategies mediated by ubiquitin-specific proteases (USPs) in cancers: new directions and therapeutic options","volume":"23","author":"Gao","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0600","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4251\/wjgo.v16.i1.197","article-title":"Comprehensive analysis of the role of ubiquitin-specific peptidases in colorectal cancer: a systematic review","volume":"16","author":"Al-Balushi","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"issue":"17","key":"10.1016\/j.bbcan.2026.189582_bb0605","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.3390\/ijms23179795","article-title":"Proteases and their potential role as biomarkers and drug targets in dry eye disease and ocular surface dysfunction","volume":"23","author":"Ramos-Llorca","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0610","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","article-title":"Oral squamous cell carcinomas: state of the field and emerging directions","volume":"15","author":"Tan","year":"2023","journal-title":"Int. J. Oral Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189582_bb0615","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3390\/ijms22030997","article-title":"Mechanisms applied by protein inhibitors to inhibit cysteine proteases","volume":"22","author":"Tu\u0161ar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189582_bb0620","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/biology14070852","article-title":"Salivaomic biomarkers \u2014 an innovative approach to the diagnosis, treatment, and prognosis of oral cancer","volume":"14","author":"Starska-Kowarska","year":"2025","journal-title":"Biol.-Basel"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189582_bb0625","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev-cancerbio-030617-050549","article-title":"Harnessing protease activity to improve cancer care","volume":"2","author":"Dudani","year":"2018","journal-title":"Annu. Rev. Cancer Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189582_bb0630","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1021\/acs.molpharmaceut.3c00148","article-title":"Radioactive and fluorescent dual modality cysteine cathepsin b activity-based probe for cancer theranostics","volume":"20","author":"Zhou","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbcan.2026.189582_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216990","article-title":"Nanoparticle-mediated metronomic chemotherapy in cancer: a paradigm of precision and persistence","volume":"594","author":"Kirti","year":"2024","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189582_bb0640","doi-asserted-by":"crossref","first-page":"51","DOI":"10.59324\/ejmhr.2024.2(2).05","article-title":"Chemotherapeutic potential of AgNP orchestrated Semecarpus anacardium nut extracts against ovarian cancer cell line, PA-1","volume":"2","author":"Lavudi","year":"2024","journal-title":"Europ. J. Med. Health Res."},{"key":"10.1016\/j.bbcan.2026.189582_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123033","article-title":"ALDH and cancer stem cells: pathways, challenges, and future directions in targeted therapy","volume":"356","author":"Lavudi","year":"2024","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189582_bb0650","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.3390\/ijms25052634","article-title":"Salivary biomarkers for oral cancer detection: An exploratory systematic review","volume":"25","author":"Bast\u00edas","year":"2024","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:48:12Z","timestamp":1780606092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":130,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0304419X26000545"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189582","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cysteine proteases in oral potentially malignant disorders: Molecular drivers, diagnostic signatures, and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189582","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189582"}}